Aerospace & Defense
Build Your Comparison
Side-by-side financial analysisStock Comparison
RAL vs CAT vs ACCO vs HON vs EMR vs KO vs JPM
Revenue, margins, valuation, and 5-year total return — side by side.
Agricultural - Machinery
Business Equipment & Supplies
Conglomerates
Industrial - Machinery
Beverages - Non-Alcoholic
Banks - Diversified
RAL vs CAT vs ACCO vs HON vs EMR vs KO vs JPM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||||
|---|---|---|---|---|---|---|---|
| Industry | Aerospace & Defense | Agricultural - Machinery | Business Equipment & Supplies | Conglomerates | Industrial - Machinery | Beverages - Non-Alcoholic | Banks - Diversified |
| Market Cap | $7.40B | $423.68B | $373M | $139.60B | $80.13B | $355.61B | $896.00B |
| Revenue (TTM) | $2.12B | $70.75B | $1.55B | $36.76B | $18.32B | $49.28B | $280.33B |
| Net Income (TTM) | $-1.24B | $9.42B | $74M | $4.10B | $2.44B | $13.70B | $57.05B |
| Gross Margin | 46.2% | 32.5% | 30.7% | 36.9% | 52.7% | 61.7% | 60.0% |
| Operating Margin | 11.9% | 16.6% | 7.9% | 14.9% | 19.8% | 29.3% | 25.9% |
| Forward P/E | 24.9x | 36.9x | 4.6x | 21.0x | 22.0x | 25.3x | 14.4x |
| Total Debt | $1.15B | $43.33B | $921M | $34.58B | $13.76B | $45.49B | $942.38B |
| Cash & Equiv. | $319M | $9.98B | $64M | $12.49B | $1.54B | $10.27B | $343.34B |
RAL vs CAT vs ACCO vs HON vs EMR vs KO vs JPM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 25 | Jun 26 | Return |
|---|---|---|---|
| Ralliant Corp. (RAL) | 100 | 136.3 | +36.3% |
| Caterpillar Inc. (CAT) | 100 | 234.6 | +134.6% |
| ACCO Brands Corpora… (ACCO) | 100 | 112.8 | +12.8% |
| Honeywell Internati… (HON) | 100 | 94.6 | -5.4% |
| Emerson Electric Co. (EMR) | 100 | 107.3 | +7.3% |
| The Coca-Cola Compa… (KO) | 100 | 116.8 | +16.8% |
| JPMorgan Chase & Co. (JPM) | 100 | 110.6 | +10.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: RAL vs CAT vs ACCO vs HON vs EMR vs KO vs JPM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Among these 7 stocks, RAL doesn't own a clear edge in any measured category.
CAT is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth 4.3%, EPS growth -14.6%, 3Y rev CAGR 4.4%
- 11.7% 10Y total return vs JPM's 465.8%
- +153.9% vs HON's -0.5%
ACCO has the current edge in this matchup, primarily because of its strength in sleep-well-at-night and defensive.
- Lower volatility, beta 1.24, current ratio 1.61x
- Beta 1.24, yield 7.1%, current ratio 1.61x
- Lower P/E (4.6x vs 25.3x)
- 7.1% yield, vs KO's 2.5%, (1 stock pays no dividend)
HON is the #2 pick in this set and the best alternative if income & stability is your priority.
- Dividend streak 8 yrs, beta 0.84, yield 2.1%
- 7.8% revenue growth vs ACCO's -8.5%
- Beta 0.84 vs RAL's 1.69
EMR doesn't hold a clear category lead here; it's more of a secondary option in this specific comparison.
KO ranks third and is worth considering specifically for quality and efficiency.
- 27.8% margin vs RAL's -58.6%
- 13.1% ROA vs RAL's -27.7%, ROIC 15.8% vs 6.2%
JPM is the clearest fit if your priority is valuation efficiency.
- PEG 0.81 vs HON's 11.42
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 7.8% revenue growth vs ACCO's -8.5% | |
| Value | Lower P/E (4.6x vs 25.3x) | |
| Quality / Margins | 27.8% margin vs RAL's -58.6% | |
| Stability / Safety | Beta 0.84 vs RAL's 1.69 | |
| Dividends | 7.1% yield, vs KO's 2.5%, (1 stock pays no dividend) | |
| Momentum (1Y) | +153.9% vs HON's -0.5% | |
| Efficiency (ROA) | 13.1% ROA vs RAL's -27.7%, ROIC 15.8% vs 6.2% |
RAL vs CAT vs ACCO vs HON vs EMR vs KO vs JPM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
RAL vs CAT vs ACCO vs HON vs EMR vs KO vs JPM — Financial Metrics
Side-by-side numbers across 7 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
KO leads in 1 of 6 categories
ACCO leads 1 • CAT leads 1 • RAL leads 0 • HON leads 0 • EMR leads 0 • JPM leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
KO leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $280.3B annually — 180.7x ACCO's $1.6B. KO is the more profitable business, keeping 27.8% of every revenue dollar as net income compared to RAL's -58.6%. On growth, CAT holds the edge at +22.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||||
|---|---|---|---|---|---|---|---|
| RevenueTrailing 12 months | $2.1B | $70.8B | $1.6B | $36.8B | $18.3B | $49.3B | $280.3B |
| EBITDAEarnings before interest/tax | $371M | $14.0B | $177M | $6.5B | $4.7B | $15.5B | $81.4B |
| Net IncomeAfter-tax profit | -$1.2B | $9.4B | $74M | $4.1B | $2.4B | $13.7B | $57.0B |
| Free Cash FlowCash after capex | $302M | $11.4B | $49M | $4.2B | $3.1B | $12.6B | $100.9B |
| Gross MarginGross profit ÷ Revenue | +46.2% | +32.5% | +30.7% | +36.9% | +52.7% | +61.7% | +60.0% |
| Operating MarginEBIT ÷ Revenue | +11.9% | +16.6% | +7.9% | +14.9% | +19.8% | +29.3% | +25.9% |
| Net MarginNet income ÷ Revenue | -58.6% | +13.3% | +4.8% | +11.2% | +13.3% | +27.8% | +20.4% |
| FCF MarginFCF ÷ Revenue | +14.2% | +16.2% | +3.2% | +11.4% | +17.0% | +25.5% | +36.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | +11.0% | +22.2% | +8.3% | -6.9% | +2.9% | +12.1% | — |
| EPS Growth (YoY)Latest quarter vs prior year | -13.3% | +30.2% | +2.4% | -41.9% | +28.2% | +18.2% | +16.0% |
Valuation Metrics
ACCO leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 9.2x trailing earnings, ACCO trades at a 81% valuation discount to CAT's 48.4x P/E. Adjusting for growth (PEG ratio), JPM offers better value at 0.90x vs HON's 16.30x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||||
|---|---|---|---|---|---|---|---|
| Market CapShares × price | $7.4B | $423.7B | $373M | $139.6B | $80.1B | $355.6B | $896.0B |
| Enterprise ValueMkt cap + debt − cash | $8.2B | $457.0B | $1.2B | $161.7B | $92.3B | $390.8B | $1.50T |
| Trailing P/EPrice ÷ TTM EPS | -6.13x | 48.36x | 9.18x | 29.93x | 35.41x | 27.18x | 16.00x |
| Forward P/EPrice ÷ next-FY EPS est. | 24.92x | 36.94x | 4.64x | 20.96x | 21.99x | 25.27x | 14.40x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.72x | — | 16.30x | 7.84x | 2.43x | 0.90x |
| EV / EBITDAEnterprise value multiple | 21.98x | 33.92x | 6.79x | 20.33x | 18.29x | 26.39x | 18.36x |
| Price / SalesMarket cap ÷ Revenue | 3.58x | 6.27x | 0.24x | 3.73x | 4.45x | 7.42x | 3.20x |
| Price / BookPrice ÷ Book value/share | 4.59x | 20.03x | 0.57x | 9.17x | 3.99x | 10.40x | 2.47x |
| Price / FCFMarket cap ÷ FCF | 20.64x | 41.24x | 7.34x | 25.89x | 30.05x | 67.15x | 8.88x |
Profitability & Efficiency
Evenly matched — CAT and KO each lead in 3 of 9 comparable metrics.
Profitability & Efficiency
CAT delivers a 47.5% return on equity — every $100 of shareholder capital generates $48 in annual profit, vs $-52 for RAL. EMR carries lower financial leverage with a 0.68x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), ACCO scores 7/9 vs RAL's 3/9, reflecting strong financial health.
| Metric | |||||||
|---|---|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -51.7% | +47.5% | +11.3% | +23.1% | +12.1% | +41.1% | +15.9% |
| ROA (TTM)Return on assets | -27.7% | +10.0% | +3.2% | +5.3% | +5.8% | +13.1% | +1.3% |
| ROICReturn on invested capital | +6.2% | +15.9% | +5.5% | +12.6% | +8.2% | +15.8% | +4.5% |
| ROCEReturn on capital employed | +7.6% | +19.1% | +6.1% | +12.6% | +10.0% | +17.3% | +8.9% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 5 | 7 | 6 | 7 | 7 | 5 |
| Debt / EquityFinancial leverage | 0.70x | 2.03x | 1.39x | 2.24x | 0.68x | 1.33x | 2.60x |
| Net DebtTotal debt minus cash | $830M | $33.4B | $856M | $22.1B | $12.2B | $35.2B | $599.0B |
| Cash & Equiv.Liquid assets | $319M | $10.0B | $64M | $12.5B | $1.5B | $10.3B | $343.3B |
| Total DebtShort + long-term debt | $1.1B | $43.3B | $921M | $34.6B | $13.8B | $45.5B | $942.4B |
| Interest CoverageEBIT ÷ Interest expense | 5.37x | 9.22x | 2.50x | 3.92x | 6.46x | 10.70x | 0.74x |
Total Returns (Dividends Reinvested)
CAT leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CAT five years ago would be worth $42,769 today (with dividends reinvested), compared to $6,044 for ACCO. Over the past 12 months, CAT leads with a +153.9% total return vs HON's -0.5%. The 3-year compound annual growth rate (CAGR) favors CAT at 57.4% vs ACCO's -0.7% — a key indicator of consistent wealth creation.
| Metric | |||||||
|---|---|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +29.2% | +52.7% | +13.6% | +13.7% | +6.2% | +20.3% | -0.5% |
| 1-Year ReturnPast 12 months | +39.5% | +153.9% | +16.7% | -0.5% | +14.6% | +17.2% | +21.8% |
| 3-Year ReturnCumulative with dividends | +39.5% | +289.8% | -2.2% | +17.5% | +77.8% | +47.0% | +138.2% |
| 5-Year ReturnCumulative with dividends | +39.5% | +327.7% | -39.6% | +7.9% | +57.7% | +65.6% | +118.2% |
| 10-Year ReturnCumulative with dividends | +39.5% | +1168.9% | -37.5% | +135.6% | +216.5% | +121.1% | +465.8% |
| CAGR (3Y)Annualised 3-year return | +11.7% | +57.4% | -0.7% | +5.5% | +21.1% | +13.7% | +33.6% |
Risk & Volatility
Evenly matched — RAL and KO each lead in 1 of 2 comparable metrics.
Risk & Volatility
KO is the less volatile stock with a -0.20 beta — it tends to amplify market swings less than RAL's 1.69 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. RAL currently trades 98.6% from its 52-week high vs EMR's 86.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||||
|---|---|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.69x | 1.67x | 1.24x | 0.84x | 1.61x | -0.20x | 0.94x |
| 52-Week HighHighest price in past year | $67.01 | $946.83 | $4.29 | $248.18 | $165.15 | $84.04 | $337.25 |
| 52-Week LowLowest price in past year | $37.27 | $355.70 | $2.81 | $186.76 | $122.64 | $65.35 | $262.71 |
| % of 52W HighCurrent price vs 52-week peak | +98.6% | +96.2% | +94.2% | +88.8% | +86.6% | +98.3% | +95.1% |
| RSI (14)Momentum oscillator 0–100 | 70.9 | 52.5 | 57.5 | 48.4 | 53.9 | 60.6 | 59.1 |
| Avg Volume (50D)Average daily shares traded | 1.4M | 2.4M | 905K | 4.1M | 2.5M | 12.7M | 7.0M |
Analyst Outlook
Evenly matched — ACCO and KO each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: RAL as "Buy", CAT as "Buy", ACCO as "Hold", HON as "Buy", EMR as "Buy", KO as "Buy", JPM as "Buy". Consensus price targets imply 98.0% upside for ACCO (target: $8) vs -10.5% for RAL (target: $59). For income investors, ACCO offers the higher dividend yield at 7.11% vs CAT's 0.64%.
| Metric | |||||||
|---|---|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $59.17 | $882.20 | $8.00 | $250.08 | $163.62 | $86.13 | $339.75 |
| # AnalystsCovering analysts | 7 | 53 | 7 | 28 | 41 | 48 | 61 |
| Dividend YieldAnnual dividend ÷ price | — | +0.6% | +7.1% | +2.1% | +1.5% | +2.5% | +1.9% |
| Dividend StreakConsecutive years of raises | 1 | 32 | 0 | 8 | 54 | 56 | 15 |
| Dividend / ShareAnnual DPS | — | $5.86 | $0.29 | $4.63 | $2.10 | $2.04 | $5.95 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +1.2% | +4.1% | +2.7% | +1.6% | +0.2% | +3.9% |
KO leads in 1 of 6 categories (Income & Cash Flow). ACCO leads in 1 (Valuation Metrics). 3 tied.
RAL vs CAT vs ACCO vs HON vs EMR vs KO vs JPM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is RAL or CAT or ACCO or HON or EMR or KO or JPM a better buy right now?
For growth investors, Honeywell International Inc.
(HON) is the stronger pick with 7. 8% revenue growth year-over-year, versus -8. 5% for ACCO Brands Corporation (ACCO). ACCO Brands Corporation (ACCO) offers the better valuation at 9. 2x trailing P/E (4. 6x forward), making it the more compelling value choice. Analysts rate Ralliant Corp. (RAL) a "Buy" — based on 7 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — RAL or CAT or ACCO or HON or EMR or KO or JPM?
On trailing P/E, ACCO Brands Corporation (ACCO) is the cheapest at 9.
2x versus Caterpillar Inc. at 48. 4x. On forward P/E, ACCO Brands Corporation is actually cheaper at 4. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: JPMorgan Chase & Co. wins at 0. 81x versus Honeywell International Inc. 's 11. 42x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — RAL or CAT or ACCO or HON or EMR or KO or JPM?
Over the past 5 years, Caterpillar Inc.
(CAT) delivered a total return of +327. 7%, compared to -39. 6% for ACCO Brands Corporation (ACCO). Over 10 years, the gap is even starker: CAT returned +1169% versus ACCO's -37. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — RAL or CAT or ACCO or HON or EMR or KO or JPM?
By beta (market sensitivity over 5 years), The Coca-Cola Company (KO) is the lower-risk stock at -0.
20β versus Ralliant Corp. 's 1. 69β — meaning RAL is approximately -945% more volatile than KO relative to the S&P 500. On balance sheet safety, Emerson Electric Co. (EMR) carries a lower debt/equity ratio of 68% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — RAL or CAT or ACCO or HON or EMR or KO or JPM?
By revenue growth (latest reported year), Honeywell International Inc.
(HON) is pulling ahead at 7. 8% versus -8. 5% for ACCO Brands Corporation (ACCO). On earnings-per-share growth, the picture is similar: ACCO Brands Corporation grew EPS 141. 5% year-over-year, compared to -502. 2% for Ralliant Corp.. Over a 3-year CAGR, EMR leads at 9. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — RAL or CAT or ACCO or HON or EMR or KO or JPM?
The Coca-Cola Company (KO) is the more profitable company, earning 27.
3% net margin versus -59. 1% for Ralliant Corp. — meaning it keeps 27. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: KO leads at 28. 7% versus 7. 1% for ACCO. At the gross margin level — before operating expenses — KO leads at 61. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is RAL or CAT or ACCO or HON or EMR or KO or JPM more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, JPMorgan Chase & Co. (JPM) is the more undervalued stock at a PEG of 0. 81x versus Honeywell International Inc. 's 11. 42x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, ACCO Brands Corporation (ACCO) trades at 4. 6x forward P/E versus 36. 9x for Caterpillar Inc. — 32. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ACCO: 98. 0% to $8. 00.
08Which pays a better dividend — RAL or CAT or ACCO or HON or EMR or KO or JPM?
In this comparison, ACCO (7.
1% yield), KO (2. 5% yield), HON (2. 1% yield), JPM (1. 9% yield), EMR (1. 5% yield), CAT (0. 6% yield) pay a dividend. RAL does not pay a meaningful dividend and should not be held primarily for income.
09Is RAL or CAT or ACCO or HON or EMR or KO or JPM better for a retirement portfolio?
For long-horizon retirement investors, The Coca-Cola Company (KO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
20), 2. 5% yield, +121. 1% 10Y return). Ralliant Corp. (RAL) carries a higher beta of 1. 69 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (KO: +121. 1%, RAL: +39. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between RAL and CAT and ACCO and HON and EMR and KO and JPM?
These companies operate in different sectors (RAL (Industrials) and CAT (Industrials) and ACCO (Industrials) and HON (Industrials) and EMR (Industrials) and KO (Consumer Defensive) and JPM (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: RAL is a small-cap quality compounder stock; CAT is a large-cap quality compounder stock; ACCO is a small-cap deep-value stock; HON is a mid-cap quality compounder stock; EMR is a mid-cap quality compounder stock; KO is a large-cap quality compounder stock; JPM is a large-cap deep-value stock. CAT, ACCO, HON, EMR, KO, JPM pay a dividend while RAL does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.